Review Article
Acute Myeloid Leukemia with the t(8;21) Translocation: Clinical Consequences and Biological Implications
Table 1
Genetic abnormalities commonly detected in combination with t(8;21).
| Abnormality | Frequency in t(8;21) AML | Documented prognostic impact | Reference |
| Chromosomal abnormalities | | | | -X in female patients | 30%–40% | None | [7, 24, 25] | -Y in male patients | 50%–60% | Possible improved | [7, 24, 25] | Del(9q) | 15%–35%; most studies state 15%–20% | None | [7, 24–26] | Trisomy 8 | 8% | | [27] | Complex abnormalities | 9%–23% | Adverse prognosis | [27–29] | Molecular abnormalities | | | | KIT mutations | 25%–50% | Possible adverse prognosis | [30–41] | JAK2V617F | 6%–8% | | [36, 42] | Flt3 -ITD | 5% | Adverse prognosis | [24, 33, 43] | Flt3 D853 | 3%–7% | | [24, 43] |
|
|